FDA declares end to Wegovy and Ozempic shortage

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss. The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022. The FDA’s announcement comes months after drugmaker Novo

Read More

CDC restores 9/11-related cancer research funding after DOGE’s cancellation, officials say

Funds restored for 9/11-related cancer research, officials say Funds restored for 9/11-related cancer research, officials say 00:48 The Centers for Disease Control and Prevention has restored a $257,000 contract for 9/11-related cancer research after the Trump administration’s Department of Government Efficiency, or DOGE, tried to cancel it, officials say. The contract pays for data processing

Read More